OpenAI backs US bills to curb AI-driven biological weapon risks in Washington
Coveragetap to expand ▾Spectrum: Mostly Center🌍Asia: 2
- OpenAI said it is endorsing a series of bipartisan bills in the United States Congress intended to help prevent AI models from accelerating the threat of biological weapons and synthetic viruses (per straitstimes.com).
- OpenAI is endorsing the Web of Biological Data Act, the AI-Ready Bio-Data Standards Act and the Scale Biology Act (per straitstimes.com).
- OpenAI backed a provision of the Frontier Act that would require leading AI companies to embed independent evaluators to assess model safety (per straitstimes.com).
- Politico earlier reported the endorsements and OpenAI’s spokesperson confirmed them on Sept 15 (per straitstimes.com).
- OpenAI has previously called for a slowdown in advanced AI development and said it was pushing for mandatory national AI safety requirements in the United States (per straitstimes.com).
OpenAI announced it is endorsing a package of bipartisan U.S. bills intended to reduce the risk that advanced AI models could accelerate the creation or spread of biological weapons and synthetic viruses.
The company’s spokesperson confirmed on Sept 15 that OpenAI supports the Web of Biological Data Act, the AI-Ready Bio-Data Standards Act and the Scale Biology Act, and separately backed a Frontier Act provision to require leading AI firms to embed independent evaluators to assess model safety (per straitstimes.com).
OpenAI framed the move as part of a broader push for mandatory national AI safety requirements and a previously stated call for a slowdown in advanced AI development (per straitstimes.com).
The endorsements follow reporting by Politico that first identified the company’s support; OpenAI’s confirmation on Sept 15 aligns the firm publicly with lawmakers pursuing legislative guardrails for AI and biological data (per straitstimes.com).
The bills OpenAI named target the governance of biological data, standards for bio‑ready datasets and scaling biology research — measures the company says would prevent misuse of AI tools on biological threats (per straitstimes.com).
OpenAI’s backing of an independent-evaluator requirement in the Frontier Act signals support for external scrutiny of frontier models, a controversial mechanism lawmakers and industry are debating as they weigh oversight of powerful AI systems (per straitstimes.com).
The company did not, in the quoted text, specify how it would implement the independent-evaluator requirement within its own development pipeline or whether it would accept particular evaluators named by Congress (per straitstimes.com).
This endorsement places a leading AI developer alongside congressional efforts to legislate biosecurity-relevant AI rules at a moment when policymakers are intensifying scrutiny of model capabilities and potential misuse (per straitstimes.com).
- Who bears concrete costs: biomedical researchers who rely on shared datasets could face new compliance burdens under the Web of Biological Data Act, increasing time and expense for academic labs to access or share datasets (per straitstimes.com).
- Who benefits: OpenAI and other leading AI firms gain political cover and influence over rule design by publicly endorsing bills that include independent-evaluator requirements, shaping how external safety reviews would be structured (per straitstimes.com).
- Specific mechanism of harm addressed: lawmakers and OpenAI aim to prevent AI models from being used to design or optimize biological weapons or synthetic viruses by regulating biological data standards and model evaluation (per straitstimes.com).
- Whether Congress advances the Web of Biological Data Act, the AI-Ready Bio-Data Standards Act or the Scale Biology Act through committee markup or floor votes this congressional session (per straitstimes.com).
- Whether the Frontier Act provision on independent evaluators is included in any final Frontier Act text and if leading AI companies adopt the specific evaluator framework specified by lawmakers (per straitstimes.com).
- Whether OpenAI or other major AI firms publish implementation plans showing how they would embed independent evaluators into model development and what standards those evaluators would use (per straitstimes.com).
- Only straitstimes.com reports OpenAI’s confirmation on Sept 15 and frames the endorsements as tied to preventing AI-enabled biological threats; Politico is cited as having reported the endorsements earlier but Politico’s original framing is not included in this pack (per straitstimes.com).
- No source text in this pack disputes OpenAI’s endorsement, but details on how independent evaluators would be selected, their powers, and enforcement mechanisms remain unspecified in the provided article (per straitstimes.com).
- No source in this pack names congressional sponsors or specific committees handling the Web of Biological Data Act, AI-Ready Bio-Data Standards Act or Scale Biology Act.
- No source provides text of the Frontier Act provision or specifies candidate independent evaluators or oversight bodies.
- No source quantifies potential compliance costs for researchers or companies or cites specific funding offsets for implementation.
- The sources do not provide differing numerical figures for the same quantity in this pack.
- The article states OpenAI’s prior calls for a slowdown and national AI safety requirements as context for the endorsements, but does not present an alternate causal account or dispute of why OpenAI endorsed the bills (per straitstimes.com).
- straitstimes.com attributes the endorsements and the Sept 15 confirmation to an OpenAI spokesperson and cites Politico as having earlier reported the endorsements (per straitstimes.com).